Stocktoria

INSULET CORP PODD

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-05-15 · LEI

INSULET CORP financials (annual)

Revenue
$367.0M $463.8M $563.8M $738.2M $904.4M $1.10B $1.31B $1.70B $2.07B $2.71B 2016201720182019202020212022202320242025
Net income
-$28.9M -$26.8M $3.3M $11.6M $6.8M $16.8M $4.6M $206.3M $418.3M $247.1M 2016201720182019202020212022202320242025
Free cash flow
-$6.2M -$32.5M -$121.5M -$65.3M -$45.0M -$180.0M -$3.9M $70.1M $305.3M $377.7M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$2.7B$2.1B$1.7B$1.3B$1.1B$904.4M$738.2M$563.8M$463.8M$367.0M
Gross profit$1.9B$1.4B$1.2B$805.6M$752.1M$582.3M$480.3M$370.2M$277.2M$211.1M
R&D expense$301.1M$219.6M$205.0M$180.2M$160.1M$146.8M$132.3M$94.8M$75.7M$55.7M
SG&A expense$1.2B$917.2M$734.8M$587.8M$466.0M$384.0M$298.0M$248.0M
Operating income$473.8M$308.9M$220.1M$37.6M$126.0M$51.5M$50.0M$27.4M-$7.4M-$10.7M
Interest expense$36.2M$36.0M$61.7M$48.1M$34.6M$28.9M$21.2M$14.4M
Income tax$92.4M-$118.1M$8.3M$5.2M$3.7M$2.9M$2.9M$1.9M$200,000$392,000
Net income$247.1M$418.3M$206.3M$4.6M$16.8M$6.8M$11.6M$3.3M-$26.8M-$28.9M
EPS (diluted)$3.48$5.78$2.94$0.07$0.24$0.10$0.19$0.05$-0.46$-0.48
Operating cash flow$569.3M$430.2M$145.7M$119.0M-$68.1M$84.0M$98.4M$35.9M$41.3M$15.9M
Free cash flow$377.7M$305.3M$70.1M-$3.9M-$180.0M-$45.0M-$65.3M-$121.5M-$32.5M-$6.2M
Cash & equivalents$907.2M$213.7M$113.9M$272.6M$137.2M
Inventory$452.6M$430.4M$402.6M$346.8M$303.2M$154.3M$101.0M$71.4M$33.8M$35.5M
Total assets$3.2B$3.1B$2.6B$2.3B$2.0B$1.9B$1.1B$928.7M$816.7M$456.6M
Total liabilities$1.7B$1.9B$1.9B$1.8B$1.5B$1.3B$1.1B$716.6M$658.2M$393.5M
Shareholders' equity$1.5B$1.2B$732.7M$476.4M$556.3M$603.6M$75.9M$212.1M$158.5M$63.1M

Growth · year-over-year · Revenue CAGR 24.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+30.7%+22.1%+30.0%+18.8%+21.5%+22.5%+30.9%+21.6%+26.4%+39.1%
Net income growth-40.9%+102.8%+4384.8%-72.6%+147.1%-41.4%+251.5%
EPS growth-39.8%+96.6%+4100.0%-70.8%+140.0%-47.4%+280.0%
Free cash flow growth+23.7%+335.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.